Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F

FEBS Letters

Volumn 466, Issue 2-3, 2000, Pages 337-340

  Pan, Ying Xian ^a   Xu, Jin ^a   Bolan, Elizabeth ^a   Chang, Albert ^a   Mahurter, Loriann ^a   Rossi, Grace ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Analgesia; Antisense mapping; MOR 1; Morphine; Morphine 6 glucuronide; Splicing

Indexed keywords

MU OPIATE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; DNA FLANKING REGION; GENE EXPRESSION; GENE ISOLATION; GENE MAPPING; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ANALYSIS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHO CELLS; CODON, TERMINATOR; CRICETINAE; DNA, COMPLEMENTARY; EXONS; MALE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033969014     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01095-4     Document Type: Article

References (26)

1. Pasternak G.W. Clin. Neuropharmacol. 16:1993;1-18.
2. Pasternak G.W., Childers S.R., Snyder S.H. Science. 208:1980;514-516.
3. Pasternak G.W., Childers S.R., Snyder S.H. J. Pharmacol. Exp. Ther. 214:1980;455-462.
4. Wolozin B.L., Pasternak G.W. Proc. Natl. Acad. Sci. USA. 78:1981;6181-6185.
5. Hahn E.F., Pasternak G.W. Life Sci. 31:1982;1385-1388.
6. Ling G.S.F., MacLeod J.M., Lee S., Lockhart S.H., Pasternak G.W. Science. 226:1984;462-464.
7. Pasternak G.W., Bodnar R.J., Clark J.A., Inturrisi C.E. Life Sci. 41:1987;2845-2849.
8. Paul D., Standifer K.M., Inturrisi C.E., Pasternak G.W. J. Pharmacol. Exp. Ther. 251:1989;477-483.
9. Rossi G.C., Pan Y.-X., Brown G.P., Pasternak G.W. FEBS Lett. 369:1995;192-196.
10. Brown G.P., Yang K., King M.A., Rossi G.C., Leventhal L., Chang A., Pasternak G.W. FEBS Lett. 412:1997;35-38.
11. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Mol. Pharmacol. 44:1993;8-12.
12. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. Proc. Natl. Acad. Sci. USA. 90:1993;10230-10234.
13. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., Loh H.H. Proc. Natl. Acad. Sci. USA. 91:1994;9081-9085.
14. Giros B., Pohl M., Rochelle J.M., Seldin M.F. Life Sci. 56:1995;PL369-PL375.
15. Rossi G.C., Pan Y.-X., Cheng J., Pasternak G.W. Life Sci. 54:1994;PL375-PL379.
16. Rossi G.C., Leventhal L., Pan Y.X., Cole J., Su W., Bodnar R.J., Pasternak G.W. J. Pharmacol. Exp. Ther. 281:1997;109-114.
17. Bare L.A., Mansson E., Yang D. FEBS Lett. 354:1994;213-216.
18. Zimprich A., Simon T., Hollt V. FEBS Lett. 359:1995;142-146.
19. Pan Y.X., Xu J., Bolan E.A., Abbadie C., Chang A., Zuckerman A., Rossi G.C., Pasternak G.W. Mol. Pharmacol. 56:1999;396-403.
20. Haley T.J., McCormick W.G. Br. J. Pharmacol. 12:1957;12-15.
21. Hylden J.L.K., Wilcox G.L. Eur. J. Pharmacol. 67:1980;313-316.
22. Pan Y.-X., Cheng J., Xu J., Pasternak G.W. Regul. Pept. 54:1994;217-218.
23. Abbadie, C., Pan, Y.-X. and Pasternak, G.W. (1999) Submitted.
24. Jordan B.A., Devi L.A. Nature. 399:1999;697-700.
25. Cheng Y.-C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099-3108.
26. Chou T.-C. Mol. Pharmacol. 10:1974;235-247.